Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948636 · ClinicalTrials.gov registry record
Stem Cell Related Donor Safety Study
A clinical trial, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- 1,812
- Enrollment target
NCT00948636: Completed study, sponsored by Center for International Blood and Marrow Transplant Research.
NCT00948636 is a clinical trial that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 1,812 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948636 has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- 1,812 participants
- Enrollment target
Study Summary
The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors. The study will also assess the hypothesis that young (\<18 years) and older (\>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations. An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,812 participants |
| Start Date | 2010-01 |
| Est. Completion | 2016-09 |
What the finished NCT00948636 record still lists
NCT00948636 is an observational study that tracks outcomes without assigning an intervention. Its 1,812 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00948636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948636 about?
NCT00948636 is a clinical study titled "Stem Cell Related Donor Safety Study". The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors. The study will also assess the hypothesis that young (\<18 ye...
What is the current status of trial NCT00948636?
This trial is currently completed. The enrollment target is 1,812 participants. The study started on 2010-01. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT00948636?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia